Nagendran J, Moore M D, Norris C M, Khani-Hanjani A, Graham M M, Freed D H, Nagendran J
Department of Surgery, University of Alberta and Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada.
Int J Obes (Lond). 2016 Apr;40(4):721-4. doi: 10.1038/ijo.2016.20. Epub 2016 Feb 8.
The purpose of this study was to compare the outcomes of patients undergoing cardiac transplantation stratified by body mass index (BMI, kg m(-)(2)). The Alberta Provincial Project for Outcome Assessment in Coronary Heart Disease registry captured 220 cardiac transplantations in Alberta, Canada from January 2004 to April 2013. All recipients were stratified by BMI into five groups (BMI: <20, 20-24.9, 25-29.9, 30-<34.9 and ⩾35). Patient characteristics were analyzed by analysis of variance and χ(2) analyses. Kaplan-Meier was used to examine survival differences. Preoperative characteristics demonstrated significant increases in metabolic syndrome, prior myocardial infarction and prior coronary artery bypass graft in patients with morbid obesity. Intra-operatively, there was an increase in cardiopulmonary bypass time in patients with morbid obesity (P<0.01). Postoperative analysis revealed increased rates of early complications (<30 days), associated with a BMI >35. Long-term survival was also significantly decreased in patients with morbid obesity. Of interest, obesity (BMI, 30-34.9) was not associated with decreased survival. These findings suggest that, post-cardiac transplantation, patients who have a BMI ⩾35 have lower long-term survival compared with all other BMI groups. However, patients with BMI 30-34.9 did not have significantly worse outcomes and should not be excluded for heart transplantation based on BMI.
本研究的目的是比较根据体重指数(BMI,kg/m²)分层的心脏移植患者的预后。加拿大阿尔伯塔省冠心病结局评估项目登记处收集了2004年1月至2013年4月在加拿大阿尔伯塔省进行的220例心脏移植病例。所有受者根据BMI分为五组(BMI:<20、20 - 24.9、25 - 29.9、30 - <34.9和⩾35)。通过方差分析和χ²分析对患者特征进行分析。采用Kaplan-Meier法检验生存差异。术前特征显示,病态肥胖患者的代谢综合征、既往心肌梗死和既往冠状动脉旁路移植术显著增加。术中,病态肥胖患者的体外循环时间增加(P<0.01)。术后分析显示,BMI>35的患者早期并发症(<30天)发生率增加。病态肥胖患者的长期生存率也显著降低。有趣的是,肥胖(BMI,30 - 34.9)与生存率降低无关。这些发现表明,心脏移植术后,BMI⩾35的患者与所有其他BMI组相比,长期生存率较低。然而,BMI为30 - 34.9的患者预后并没有显著更差,不应基于BMI而被排除在心脏移植之外。